CSRXP: PUBLIC-PRIVATE PARTNERSHIP WILL HELP DELIVER RELIEF FROM BIG PHARMA’S INSULIN PRICE-GOUGING

05-27-2020 Blog Posts

Coalition Applauds Positive Step from the Administration to Lower Insulin Prices, Encourages Additional Action to Hold Drug Companies Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) welcomed the announcement of a public-private partnership to help lower insulin prices for Medicare beneficiaries Tuesday. The move […]

BIG PHARMA EARNINGS WATCH: AMGEN, ABBVIE & BRISTOL-MYERS SQUIBB

05-7-2020 Blog Posts

Brand Name Drug Companies Complete Sweep of Big Pharma Giants Who Beat Wall Street Expectations After Price Hikes In January In a final round of first quarter earnings reports, three more Big Pharma giants announced they surpassed earnings expectations after hiking prices on American patients. Amgen, AbbVie and Bristol-Myers Squibb all reported sky-high profits after […]

DOSE OF REALITY: BIG PHARMA NEGLECTED ANTIVIRAL, VACCINE RESEARCH IN RUN-UP TO COVID-19 CRISIS

04-30-2020 Blog Posts

Drug Companies’ Focus on Most Profitable Treatments Hampers Pandemic Readiness Big Pharma neglected antiviral and vaccine research and development (R&D) for years in the run-up to the COVID-19 pandemic — despite frequent warnings from public health experts. The reason? The industry doggedly pursued, and pushed for public funding, into treatments viewed as more lucrative. In […]

BIG PHARMA EARNINGS WATCH: ASTRAZENECA & GLAXOSMITHKLINE

04-29-2020 Blog Posts

Brand Name Drug Companies See Surging Profits After Hiking Prices Today, brand name drug giants AstraZeneca and GlaxoSmithKline (GSK) announced rising profits for the first quarter of 2020 – topping analysts’ expectations.  AstraZeneca AstraZeneca reported a net profit of $780 million, up from $593 million in the same period a year earlier. Sales for the […]

BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER

04-28-2020 Blog Posts

Big Pharma Giants Continue to Outpace Expectations After Hiking Prices New first quarter earnings reports released this week from Big Pharma giants Merck, Novartis and Pfizer demonstrate yet again that price hikes continue to support cushy profits for brand name drug companies. All three pharmaceutical manufacturers beat Wall Street expectations for the first quarter of […]

BIG PHARMA EARNINGS WATCH: SANOFI

04-27-2020 Blog Posts

Big Pharma Giant Sees Profits Soar After Price Hikes Big Pharma giant Sanofi topped earnings expectations while continuing to hike prices on the products in its portfolio, new earnings show. The brand name drug company keeps a trend alive that’s been consistent for three of the world’s largest pharmaceutical manufacturers who have reported earnings so […]

Big Pharma Watch: Drug Company Triples Price Of Potential COVID-19 Treatment

04-23-2020 Blog Posts

Jaguar Health Hikes Prices on HIV/AIDS Medication After Asking FDA to Expand Its Use for Coronavirus ICYMI, Jaguar Health, the manufacturer of brand name Mytesi, recently just tripled “the price of its lone FDA-approved drug, right after asking the federal government to expand the use of its drug to coronavirus patients,” Axios reports. At the […]

Big Pharma Earnings Watch: Eli Lilly

04-23-2020 Blog Posts

Brand Name Giant ‘Smashes’ Wall Street Expectations After Price Hikes on Diabetes, Cancer Medications New first quarter earnings reports released today from brand name giant Eli Lilly prove once again that repeated price hikes continue to support big time profits for Big Pharma. Eli Lilly bested Wall Street expectations after hiking prices on blockbuster on […]

Big Pharma Earnings Watch: Roche

04-22-2020 Blog Posts

Swiss Drug Company Repeatedly Hikes Prices as Sales Surge New first quarter earnings released today from brand pharmaceutical company Roche showed higher than expected sales on blockbuster drugs for the first quarter of 2020. Sales for the Swiss drug giant’s pharmaceutical division jumped seven percent from last year and are expected to grow in the […]

Big Pharma Earnings Watch: Johnson & Johnson

04-14-2020 Blog Posts

Price Hikes Fuel Better Than Expected Earnings For Brand Name Giant As millions of Americans struggle to afford their medications amid unprecedented health care and economic challenges, the first earnings report from a Big Pharma giant demonstrates that hiking prices on American patients continues to be a profitable practice for the industry. Today, brand name […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.